Skip to main content
Premium Trial:

Request an Annual Quote

Consolidation History in the Bioinformatics Sector, as Tracked by BioInform, 2003

Premium

January: Structural Genomics, GeneFormatics announce plans to merge (relaunch as Cengent Therapeutics in May)

February: Viaken Systems closes

February: Phase-it acquired by Europroteome

March: Molecular Mining closes (former employees license technology and launch Predictive Patterns in June)

April: Argentys (formerly Blackstone) acquired by TurboWorx

April: LabBook discontinues retail operations; Rescentris licenses technology

June: AnVil closes

June: Molecular Ware acquired by CalbaTech

August: Physiome Sciences acquired by Predix Pharmaceuticals (former Physiome employees license technology and launch the BioAnalytics Group in October)

September: Time Logic acquired by Active Motif

September: Incellico’s assets acquired by Genstruct

November: Celltech closes Confirmant database business (picked up via OGS acquisition in May)

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.